David Lopez, DrPH, M.P.H., M.S.

• Cancer Epidemiology and health disparities, Epidemiologic Methods, Pharmacoepidemiology

 Featured Publications

Racial/ethnic disparities in the association of environmental exposure to phthalates and bisphenols mixtures with diabetes mellitus: NHANES 2013-2016.

Hernández-Pérez JG, Valenzuela-Sánchez A, López DS, Torres-Sánchez L, Arch Environ Occup Health 2025 Mar 1-13

Incidence of prostate, colorectal and male breast cancers in relation with statins and testosterone replacement therapy: SEER-Medicare 2007-2015.

Abdelgadir O, Hussain MR, Polychronopoulou E, Tsilidis KK, Alzweri L, Villasante-Tezanos A, Baillargeon J, Canfield S, Kuo YF, Lopez DS, Cancer Epidemiol 2024 Oct 92 102633

Association of electronic-cigarette, number of cigarettes, and marijuana use with high-risk Human Papillomavirus (HPV) among men and women: A cross-sectional analysis of a nationally representative sample.

David SV, Villasante-Tezanos A, Bustamante G, Agana-Norman DFG, Amith M, Martinez J, Cano MÁ, Torres-Sánchez LE, Rodriguez AM, Lopez DS, Ann Epidemiol 2024 Sep 97 52-61

Association of total and free testosterone with cardiovascular disease in a nationally representative sample of white, black, and Mexican American men.

Lopez DS, Taha S, Gutierrez S, Villasante-Tezanos A, Khalife WI, Alzweri L, Markides K, Baillargeon J, Tsilidis KK, Int J Impot Res 2024 Jun 36 4 385-393

Association of serum testosterone with chronic obstructive pulmonary disease (COPD) in a nationally representative sample of White, Black, and Hispanic men.

David SV, Gibson D, Villasante-Tezanos A, Alzweri L, Hernández-Pérez JG, Torres-Sánchez LE, Baillargeon J, Lopez DS, Hormones (Athens) 2024 Mar 23 1 153-162

Association of sleep duration and quality with serum testosterone concentrations among men and women: NHANES 2011-2016.

Hernández-Pérez JG, Taha S, Torres-Sánchez LE, Villasante-Tezanos A, Milani SA, Baillargeon J, Canfield S, Lopez DS, Andrology 2024 Mar 12 3 518-526

Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: Surveillance, Epidemiology, and End Results-Medicare 2007-2015.

Hussain MR, Abdelgadir O, Polychronopoulou E, Tsilidis KK, Alzweri L, Villasante-Tezanos A, Baillargeon J, Canfield S, Kuo YF, Lopez DS, Andrology 2024 Feb

Testosterone Replacement Therapy in Relation With Cardiovascular Disease in Cisgender Women and Transgender People.

Lopez DS, Mulla JS, El Haddad D, Tahashilder MI, Polychronopolou E, Baillargeon J, Kuo YF, Gilani S, Khalife WI, J Clin Endocrinol Metab 2023 Nov 108 12 e1515-e1523

Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.

Lopez DS, Kim H, Polychronopoulou E, Torres-Sanchez LE, Villasante-Tezanos A, Baillargeon J, Canfield S, Kuo YF, J Cancer Res Clin Oncol 2023 Sep 149 11 8255-8265

Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.

Lopez DS, Malagaris I, Polychronopoulou E, Tsilidis KK, Milani SA, Kristen Peek M, Villasante-Tezanos A, Alzweri L, Baillargeon J, Kuo YF, Canfield S, Clin Endocrinol (Oxf) 2022 Dec 97 6 792-803